S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...
Genome evolution is the process by which a genome changes in structure over time, through mutation, horizontal gene transfer, and sexual reproduction. The study of genome evolution involves ...
Emergency department visits are "high" and "very high" for flu and RSV, respectively, and "elevated" for COVID-19 across the U.S., according to the CDC. As of the week ending Jan. 4, 18.6% of ...
In the week ending Jan. 10, flu positivity testing was up 20% in California. The report shows moderate RSV activity and low COVID-19 activity in the same period. Norovirus, which causes sudden ...
Respiratory syncytial virus (RSV) causes cold-like symptoms in most people but can cause more serious problems in some, especially babies and older adults. Almost all children get RSV at least once by ...
This includes more than $3 billion in COVID-19 vaccine sales and minimal sales from the RSV vaccine mResvia ... of its investigational in vivo genome-editing candidate, Nexiguran ziclumeran ...
Advances in genetic technology, spurred by the Human Genome Project, have revolutionized cancer risk assessment and management. The guideline underscores the importance of understanding personal ...
Staying healthy this year means guarding against what health officials are calling a “quad-demic” – a quartet of infectious viruses. The trifecta of flu, COVID-19 and RSV is bad enough, but this year ...
Cases of influenza, RSV, COVID-19 and norovirus are surging at the same time Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader's Digest.
Genome India project: The Department of Biotechnology recently announced its new platform and framework for sharing its 10,000 human genome dataset. The sequences of healthy individuals — from 99 ...